Telix Pharmaceuticals | 税前利润

股票价格
9.85
每天变化
-0.28 -2.76%
每月一次
-10.54%
每年
-65.99%
Q1 预测
10.34


金融业
股票价格
AUD
资产
AUD 1.52B
现金及等价物
AUD 710.35M
销售成本
AUD 148.66M
流动资产
AUD 918.56M
流动负债
AUD 330.91M
债务
AUD 581.45M
EBIT
AUD 37.44M
EBITDA
AUD 33.24M
EPS每股收益
AUD 0.28
股本和储备
AUD 568.21M
销售毛利
AUD 129.12M
债务利息支出
AUD 18.84M
利息收入
AUD 1.37M
贷款资金
AUD 551.82M
市值
AUD 3.19B
净收入
AUD 10.13M
营业费用
AUD 191.9M
营业利润
AUD 17.72M
普通股股本
AUD 587.41M
PE价格收益
AUD 164.4
税前利润
AUD 76.73M
销售收入
AUD 309.72M
销售和管理费用
AUD 55.91M
股票
AUD 38.14M
贸易债权人
AUD 68.7M
应收帐款人
AUD 158.99M


税前利润 更改 日
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 1.4B 1.14B 2025-06
Integral Diagnostics AUD 14.49M 47.37M 2024-06
Mayne Pharma AUD -14.7M 42.91M 2024-12
Medical Developments International AUD -149K 466K 2025-06
Mesoblast USD -54.09M 6.37M 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Pacific Edge NZD -714K 49K 2024-03
Polynovo AUD 1.82M 3.89M 2025-06
PYC Therapeutics AUD -12.57M 13.3M 2025-06
Ramsay Health Care AUD 103.75M 54.35M 2025-06
ResMed USD 496.15M 13.77M 2025-12
Sonic Healthcare AUD 402.01M 53.16M 2025-06


Telix Pharmaceuticals 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.